Skip to main content

문준호 교수

Joon Ho Moon

서울대학교 내과 · 의학

연구실 소개

문준호 교수의 연구실은 주로 간질환, 특히 지방간질환과 대사성 간질환(MASLD)의 심혈관계 합병증 위험을 규명하는 데 초점을 맞추고 있으며, 특히 전국 대규모 건강검진 데이터를 기반으로 한 장기적 관찰 연구를 통해 질병의 전개 양상과 예후를 분석합니다. 또한 혈액 질환 및 종양학 분야에서는 다발성골수종의 영상학적 예후 인자나 이식 후 간성면역반응(GVHD)의 새로운 평가 체계 개발에도 기여하고 있습니다. 특히 PET/CT와 MRI를 활용한 정밀 영상 기반 예측 모델 개발이 핵심 연구 전략입니다.

지방간질환예후 평가PET/CT다발성골수종이식합병증

연구 현황

논문 수
359
총 인용 수
3,658
최근 5년 논문
84
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
84총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
636총합
20222023202420252026

주요 논문

15
1
논문|인용수 160·2023
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study
Joon Ho Moon, Seogsong Jeong, Heejoon Jang, Bo Kyung Koo, Won Kim
SJR Q1EClinicalMedicineOA

Background The various subcategories under the overarching term of steatotic liver disease (SLD) have been recently proposed by the nomenclature consensus group and endorsed by international academic liver societies. Our aim was to investigate the association between each subtype of SLD and incident cardiovascular disease (CVD) in a nationwide Korean cohort. Methods From a nationwide health screening database from Korea, 351,068 individuals aged 47–86 years between January 1, 2009 and December 3

EpidemiologyMedicine
2
논문|인용수 59·2017
Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus
문준호, 곽수헌, 장학철

Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset or first recognition during pregnancy, is characterized by underlying maternal defects in the β-cell response to insulin during pregnancy. Women with a previous history of GDM have a greater than 7-fold higher risk of developing postpartum diabetes compared with women without GDM. Various risk factors for postpartum diabetes have been identified, including maternal age, glucose levels in pregnancy, famil

3
논문|인용수 45·2014
Validation of National Institutes of Health Global Scoring System for Chronic Graft-Versus-Host Disease (GVHD) According to Overall and GVHD-Specific Survival
Joon Ho Moon, Sang Kyun Sohn, Anna Lambie, Laura Ellis, Nada Hamad, Jieun Uhm, Vikas Gupta, Jeffrey H. Lipton, Hans A. Messner, John Kuruvilla, Dennis Kim
Biology of Blood and Marrow TransplantationOA

A new severity grading system for graft-versus-host disease (GVHD) was established by the National Institutes of Health (NIH) consensus criteria (NCC). However, its prognostic value still needs to be validated. Four hundred twenty-five consecutive patients who survived beyond 100 days after allogeneic stem cell transplantation were reviewed and reclassified using NCC. GVHD-specific survival (GSS) and cumulative incidence of relapse were compared according to the NIH global score at the onset and

HematologyMedicine
4
논문|인용수 42·2011
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients
Joon Ho Moon, Sang Kyun Sohn, Shi Nae Kim, Seon Yang Park, Sung Soo Yoon, In Ho Kim, Hyeoung Joon Kim, Yeo Kyeoung Kim, Yoo Hong Min, June‐Won Cheong, Jin Seok Kim, Chul Won Jung
SJR Q1Medical Oncology
HematologyMedicine
5
논문|인용수 36·2009
BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients
Joon Ho Moon, Sang Kyun Sohn, Myung-Hoon Lee, Jun Ho Jang, Kihyun Kım, Chul Won Jung, Dong Hwan Kim
SJR Q2Leukemia Research
HematologyMedicine
6
논문|인용수 29·2010
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment
Joon Ho Moon, Shi Nae Kim, Byung Woog Kang, Yee Soo Chae, Jong Gwang Kim, Jin Ho Baek, Jae Hoo Park, Moo Kon Song, Joo Seop Chung, Jong-Ho Won, Sang Min Lee, Young Don Joo
SJR Q2Annals of Hematology
HematologyMedicine
7
논문|인용수 27·2020
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial
Ho‐Young Yhim, T. Kim, Seung Ju Kim, Ho‐Jin Shin, Youngil Koh, Jin Sung Kim, Jinny Park, G.S. Park, Woo Seob Kim, Joon Ho Moon, Deok‐Hwan Yang
SJR Q1Annals of OncologyOA
Pathology and Forensic MedicineMedicine
8
논문|인용수 25·2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT
Hee Jeong Cho, Sung-Hoon Jung, Jae‐Cheol Jo, Yoo Jin Lee, Sang Eun Yoon, Sung‐Soo Park, Do Young Kim, Ho‐Jin Shin, Yeung‐Chul Mun, Jun Ho Yi, Hyo Jung Kim, Da Jung Kim
SJR Q1Blood Cancer JournalOA

Abstract In multiple myeloma (MM), a high number of focal lesions (FL) detected using positron emission tomography/computed tomography (PET/CT) was found to be associated with adverse prognosis. To design a new risk stratification system that combines the Revised International Staging System (R-ISS) with FL, we analyzed the data of 380 patients with newly diagnosed MM (NDMM) who underwent 18 F-fluorodeoxyglucose ( 18 F-FDG) PET/CT upon diagnosis. The K-adaptive partitioning algorithm was adopted

HematologyMedicine
9
논문|인용수 17·2011
The Diagnostic Accuracy, Image Quality and Radiation Dose of 64-Slice Dual-Source CT in Daily Practice: a Single Institution’s Experience
문준호, 박은아, 이활, Yong Hu Yin, 정진욱, 박재형, 이해영, 강현재, 김효수

Objective: We wanted to evaluate the image quality, diagnostic accuracy and radiation exposure of 64-slice dual-source CT (DSCT) coronary angiography according to the heart rate in symptomatic patients during daily clinical practice. Materials and Methods: We performed a retrospective search for the DSCT coronary angiography reports of 729 consecutive symptomatic patients. For the 131 patients who underwent invasive coronary angiography, the image quality, the diagnostic performance (sensitivity

10
논문|인용수 15·2015
Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML
Jae‐Sook Ahn, Hyeoung‐Joon Kim, Yeo‐Kyeoung Kim, Sung‐Hoon Jung, Deok‐Hwan Yang, Je‐Jung Lee, Nan Young Kim, Seung Hyun Choi, Chul Won Jung, Jun‐Ho Jang, Hee‐Je Kim, Joon Ho Moon
SJR Q2Annals of Hematology
HematologyMedicine
11
논문|인용수 14·2010
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset
Joon Ho Moon, S N Kim, Byung Woog Kang, Y.S. Chae, J G Kim, Jae‐Sook Ahn, Y K Kim, Deok‐Hwan Yang, J J Lee, H J Kim, Young Jin Choi, Ho‐Jin Shin
SJR Q1Bone Marrow Transplantation
SurgeryMedicine
12
논문|인용수 14·2020
Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma
Dong Won Baek, Hee Jeong Cho, Jae Heung Bae, Sang Kyun Sohn, Joon Ho Moon
SJR Q2Blood ResearchOA

BACKGROUND: This study attempted to identify novel prognostic factors in patients with newly diagnosed primary central nervous system lymphoma (PCNSL) using magnetic resonance imaging (MRI). METHODS: We retrospectively evaluated 67 patients diagnosed with central nervous system (CNS) tumors. The enrollment criteria were as follows: i) pathologic diagnosis of CNS lymphoma, ii) no evidence of systemic involvement, iii) no evidence of human immunodeficiency virus-1 infection or other immunodeficien

NeurologyMedicine
13
논문|인용수 14·2009
Clinical Significance of Autoantibody Expression in Allogeneic Stem-Cell Recipients
Joon Ho Moon, Soo-Jung Lee, Jong-Gwang Kim, Y.S. Chae, Shi-Nae Kim, Byung-Woog Kang, Jang Soo Suh, Kun-Soo Lee, Sang‐Kyun Sohn
SJR Q1Transplantation

The occurrence of autoantibodies after allogeneic stem-cell transplantation was found to be related to cGVHD, and patients expressing autoantibodies had a better survival.

HematologyMedicine
14
논문|인용수 13·2022
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
Dong Won Baek, Hee Jeong Cho, Ju‐Hyung Kim, Jae Sook Ahn, Hyeoung‐Joon Kim, Sung Nam Lim, June‐Won Cheong, Sung‐Yong Kim, Ho Sup Lee, Jong-Ho Won, Ho‐Young Yhim, Sang Kyun Sohn
SJR Q1Cell TransplantationOA

In this multicenter phase II study, we evaluated the safety and efficacy of imatinib in patients with steroid-resistant chronic graft-versus-host disease (cGVHD) and evaluated the quality of life (QOL) of the enrolled patients using the Short Form 36 (SF-36) health survey questionnaire. Thirty-six patients who were diagnosed with steroid-refractory cGVHD and treated with imatinib between March 2013 and February 2019 received 100 mg/day of imatinib for 2 weeks. Depending on the patient's conditio

HematologyMedicine
15
논문|인용수 11·2017
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD
Joon Ho Moon, Nada Hamad, Sang Kyun Sohn, Jieun Uhm, Naheed Alam, Vikas Gupta, Jeffrey H. Lipton, Hans A. Messner, Matthew D. Seftel, John Kuruvilla, Dennis Dong Hwan Kim
SJR Q2Annals of Hematology
HematologyMedicine

대표 연구 분야

HematologyPathology and Forensic MedicineGeneticsMolecular BiologyPublic Health, Environmental and Occupational HealthEpidemiology

문준호 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.